BOD


Decibel Announces New Board of Directors and Issues Letter to Shareholders

December 12th, 2022 - Ryan Allway

CALGARY, AB, Dec. 12, 2022 /CNW/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce the results of its annual general meeting of shareholders held on December 9, 2022 (the  “Meeting”).   Logo (CNW Group/Decibel Cannabis Company Inc.) Results of the Meeting Decibel’s shareholders approved all matters […]

Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors

November 1st, 2022 - Ryan Allway

AUSTIN, Texas, November 01, 2022–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), today announced the appointment of Dr. Nat Calloway to its Board of Directors. Dr. Calloway will serve as a member of the Compensation […]

Lotus Appoints Albert Duwyn as Chair of the Board

October 6th, 2022 - Ryan Allway

VANCOUVER, BC / ACCESSWIRE / October 6, 2022 / Lotus Ventures Inc. (CSE:J)(OTC PINK:LTTSF) (“Lotus” or the “Company“) a licensed cannabis producer, wholesaler, and the owner and operator of Lotus Cannabis Co.™, a premium-craft consumer brand in Canada, is pleased to announce the appointment of Albert Duwyn as its new Chairman of the Board of Directors […]

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board

September 12th, 2022 - Ryan Allway

Pioneer Entertainment Executive to Extend Digital Media Expertise to Company’s Mission in Tobacco Harm Reduction and Raise Profile in Hemp/Cannabis Industry BUFFALO, N.Y., Sept. 12, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced […]

BellRock Brands Announces Changes to Board of Directors and Agreement to Acquire Michigan Licensed Operator

September 12th, 2022 - Ryan Allway

DENVER, Sept. 12, 2022 /CNW/ – BellRock Brands Inc. (“BellRock” or the “Company”) (CSE: BRCK.U) an industry-leading cannabis consumer packaged goods (“CPG”) and intellectual property platform, announces that Chairman of the Board of Directors, Andrew Schweibold, and Director, Jonathan Rosenthal, are resigning in good standing with the Company from their respective roles on the Board, effective immediately.   BellRock Brands […]

LUFF Completes Acquisition of Licensed Producer and Appoints Herb Dhaliwal to Board

August 15th, 2022 - Ryan Allway

Vancouver, B.C. – Luff Enterprises Ltd., (CSE: LUFF) (“LUFF” or the “Company”) is pleased to announce the completion of its previously announced acquisition of the National Green Biomed group of companies (“NG Biomed”). Based in British Columbia, NG Biomed is a licensed producer of cannabis products for both the recreational and medical consumer markets. This acquisition represents the […]

AUDACIOUS Appoints Jill Swainson to Board

July 5th, 2022 - Ryan Allway

Former Chief Legal Counsel at Aurora Brings Deep International Cannabis Regulatory Expertise   LAS VEGAS, NV / ACCESSWIRE / July 5, 2022 / Australis Capital Inc. (CSE:AUSA)(OTCQB:AUSAF) (“AUSA”, “AUDACIOUS”, or the “Company”), today announced that Jill Swainson has been appointed as member of the Board of Directors. Ms. Swainson will replace Mr. Avi Gellar who served […]

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

June 23rd, 2022 - Ryan Allway

TORONTO-June 23, 2022-(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced certain changes to its board of directors (the “Board”) and the postponement of its annual general meeting of shareholders, originally scheduled to take place on June 24, 2022 (the “Meeting”).   Effective immediately, the Board has been reconstituted, by shareholder resolution, to consist of […]

Tryp Therapeutics Strengthens Board of Directors with Appointment of Chris Ntoumenopoulos as Independent Director

May 25th, 2022 - Ryan Allway

Industry leader Chris Ntoumenopoulos to support biotech Company’s mission to advance the delivery of psychedelic medicines San Diego, California — (May 25, 2022) – Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company”), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today the appointment of Chris […]

India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors

March 23rd, 2022 - Ryan Allway

POTOMAC, Md., March 23, 2022–(BUSINESS WIRE)–India Globalization Capital, Inc. (NYSE American: IGC) announces that the Board has appointed Ms. Claudia Grimaldi as a non-independent Director, effective March 23, 2022. IGC now has 5 directors including a majority who are independent.   Ms. Grimaldi has been with IGC for almost 12 years with increasing responsibilities including […]

Flora Growth Appoints Former Amazon Executive Tim Leslie to Its Board of Directors and Names CEO Luis Merchan Chairman

March 17th, 2022 - Ryan Allway

Flora Growth’s CEO Luis Merchan is named Chairman of the Board of Directors. Tim Leslie, Chairman of Flora’s Advisory Board, will join the Flora Board of Directors and audit committee. Changes to the Board of Directors signal the Company’s move toward becoming a U.S.-based issuer and will support Flora’s growth into new international markets.   […]

WM Technology, Inc. Appoints Anthony Bay as New Chairman of Company’s Board of Directors

March 10th, 2022 - Ryan Allway

IRVINE, Calif., March 10, 2022–(BUSINESS WIRE)–WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), the leading marketplace and technology solutions provider to the cannabis industry, today announced the appointment of Anthony Bay as the new Chairman of the Company’s Board of Directors. Effective immediately, Bay will succeed Chris Beals who was serving as the […]

Vext Announces Appointment of Highly Experienced Global Executive and Director Mark W. Opzoomer to the Company’s Board of Directors

February 10th, 2022 - Ryan Allway

VANCOUVER, BC, Feb. 10, 2022 /CNW/ – Vext Science, Inc. (“Vext” or the “Company”) (CSE: VEXT) (OTCQX: VEXTF), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that Mark W. Opzoomer, a highly experienced global executive and director, has been appointed to the Company’s board […]

The Parent Company Announces Voluntary Extension of Boar of Director and Leadership Team Lock-Up Agreements

January 28th, 2022 - Ryan Allway

~35% of the Company’s Common Shares to Be Voluntarily Locked-Up for An Additional Twelve Months SAN JOSE, Calif, Jan. 28, 2022 /CNW/ – TPCO Holding Corp. (“The Parent Company” or the “Company”) (NEO: GRAM.U) (OTCQX: GRAMF), a leading vertically-integrated California cannabis company, announced today that certain insiders (the “Insiders”) have individually voluntarily entered into a twelve-month extension of lock-up […]

The Newly Institute Announces Appointment of Danny Williams, Former Premier of Newfoundland and Labrador, to Board of Directors

January 24th, 2022 - Ryan Allway

Mr. Williams’ strong business acumen and corporate governance experience will be valuable to The Newly Institute as it continues to expand its inter-disciplinary mental health clinics across Canada   Calgary, Alberta–(Newsfile Corp. – January 24, 2022) – The Newly Institute Inc. (“The Newly” or the “Company“), Canada’s leading inter-disciplinary mental health clinical organization that offers […]

Item 9 Labs Corp. Enhances Board of Directors with Two Independent Appointments

January 4th, 2022 - Ryan Allway

Names Eric C. Kutscher and Lawrence X. Taylor to Board of Directors; Adds a Combined 55-Plus Years of Experience Across Patient-Centered Healthcare, Leadership, M&A and Strategic Planning   PHOENIX, Jan. 4, 2022 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”)—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that Eric C. Kutscher, Pharm. […]

Generation Hemp Announces Results of Certain Board of Directors Administrative Matters

September 10th, 2021 - Ryan Allway

Board Committee Appointments Adoption of Governance Documents Change of Domicile Conversion of the Company’s Outstanding Series A Preferred Stock   DALLAS, September 10, 2021–(BUSINESS WIRE)–Generation Hemp, Inc. (the “Company”), a Dallas/Fort Worth based midstream hemp company (OTCQB: GENH), today announced recent corporate developments, including the results of the Company’s recent Board of Directors meeting held […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading